Harry Khasigian MD in Sacramento, California

Additional Medical Specialties Include:
SPORTS MEDICINE

Medical School: University Of Southern California Keck School Of Medicine
Graduation Year: 1974
The Primary Medical Specialty for Harry Khasigian MD is listed as: Orthopedic Surgery
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 50
PAC (PECOS ID)#: 7517954936
NPI #: 1275505562
NPI Created On: 02/02/2006
NPI Last Updated Listed as: 04/20/2018
Primary Taxonomy Code: 207XX0005X
License Number:
G29772
Listed Gender: Male

---

Forms of insurance accepted by include, but are not limited to:

• Humana
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish.

---

Services and Procedures include:

1. Removal of foreign material from skin and tissue at open fracture and/or dislocation
2. Aspiration and/or injection of large joint or joint capsule
3. Replacement of thigh bone and hip joint prosthesis
4. Surgical treatment of broken thigh bone
5. Repair of knee joint
6. X-ray of spine of neck, 2 or 3 views
7. X-ray of lower and sacral spine, 2 or 3 views
8. X-ray of pelvis, 1 or 2 views
9. X-ray of shoulder, minimum of 2 views
10. X-ray of wrist, minimum of 3 views
11. X-ray of hip with pelvis, 1 view
12. X-ray of knee, 3 views
13. X-ray of ankle, minimum of 3 views
14. New patient office or other outpatient visit, typically 45 minutes
15. Established patient office or other outpatient visit, typically 15 minutes
16. Established patient office or other outpatient, visit typically 25 minutes
17. Established patient office or other outpatient, visit typically 40 minutes
18. Initial hospital inpatient care, typically 50 minutes per day

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

They took part in the Million Hearts Initiative, which was deigned to improve cardiac outcomes.